Cipla, one of India's largest drug manufacturers, said it has reverse engineered Roche's Tamiflu and plans to start offering commercial quantities of a copycat flu drug by January. The move is likely ...

Cipla likely benefited from high seasonal demand for flu medicines, with incidences of infection in the December quarter much higher than in the past seven to eight years, analysts at Nomura said ...

Jerome Smith, the chief executive of Cipla-Medpro, said the group could provide the first generic drug for highly pathogenic bird flu should there be an outbreak in South Africa. Cipla said it ...

"This partnership is a significant step towards making preventive healthcare accessible to a large number of Indians through Cipla's strong countrywide sales force," said Subhanu Saxena ...